Home
United States Code
U.S.C. Title 42-THE PUBLIC HEALTH AND WELFARE
CHAPTER 6A-PUBLIC HEALTH SERVICE
SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME
Part A-Genetic Diseases

42 U.S. Code § 300b-9

PREV NEXT

Evaluating the effectiveness of newborn and child screening and followup programs

Ok Cancel

Don't show this message again

42 U.S. Code § 300b-9. Evaluating the effectiveness of newborn and child screening and followup programs

(a) In general

The Secretary shall award grants to eligible entities to provide for the conduct of demonstration programs to evaluate the effectiveness, including with respect to timeliness, of screening, followup, counseling or health care services in reducing the morbidity and mortality caused by heritable disorders in newborns and children.

This document is only available to subscribers. Please log in or purchase access.

Purchase Login

PREV NEXT

Navigation

Current through

The United States Code on COSMOS is current through Public Law 118-34 (12/26/2023), except for Public Law 118-31.

Part A-Genetic Diseases

§300b Repealed. Pub. L. 97-35, title XXI, § 2193(b)(1), Aug. 13, 1981, 95 Stat. 827
§300b-1 Research project grants and contracts
§300b-2 Voluntary participation by individuals
§300b-3 Application; special consideration to prior sickle cell anemia grant recipients
§300b-4 Public Health Service facilities
§300b-5 Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
§300b-6 Applied technology
§300b-7 Tourette Syndrome
§300b-8 Improved newborn and child screening for heritable disorders
§300b-9 Evaluating the effectiveness of newborn and child screening and followup programs
§300b-10 Advisory Committee on Heritable Disorders in Newborns and Children
§300b-11 Clearinghouse of newborn screening information
§300b-12 Laboratory quality and surveillance
§300b-13 Interagency Coordinating Committee on Newborn and Child Screening
§300b-14 National contingency plan for newborn screening
§300b-15 Hunter Kelly Research Program
§300b-16 Authorization of appropriations for newborn screening programs and activities
§300b-17 Report by Secretary

U.S. Code Popular Name Table

Popular Names

Americans with Disabilities Act 42 U.S.C. § 12101 et seq.

Anti-Kickback Statute 42 U.S.C. § 1320a–7b(b)

Clayton Act 15 U.S.C. § 12 et seq.

Clean Air Act 42 U.S.C. § 7401 et seq.

Commodity Exchange Act 7 U.S.C. § 1

Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA) 42 U.S.C. § 9601 et seq.

Controlled Substances Act 21 U.S.C. § 801 et seq.

Emergency Medical Treatment and Labor Act (EMTALA) 42 U.S.C. § 1395dd

Fair Credit Reporting Act 15 U.S.C. § 1681

False Claims Act 31 U.S.C. § 3729 et seq.

Federal Food, Drug, and Cosmetic Act 21 U.S.C. § 301 et seq.

Federal Insecticide, Fungicide, and Rodenticide Act 7 U.S.C. § 136 et seq.

Federal Trade Commission Act 15 U.S.C. § 41 et seq.

Foreign corrupt Practices Act 15 U.S.C. § 78dd-1 et seq.

Fraud Enforcement and Recovery Act of 2009 (FERA) 18 U.S.C. § 27

Health Information Technology for Economic and Clinical Health Act (HITECH) 42 U.S.C. § 300jj et seq., 42 U.S.C. § 17901 et seq.

Health Insurance Portability and Accountability Act of 1996 (HIPAA) 42 U.S.C. § 201

National Environmental Policy Act (NEPA) 42 U.S.C. § 4321 et seq.

Patient Protection and Affordable Care Act 42 U.S.C. § 18001 et seq.

Physician Payments Sunshine Act 42 U.S.C. § 1320a–7h

Public Health Service Act 42 U.S.C. § 201 et seq.

Resource Conservation and Recovery Act (RCRA) 42 U.S.C. § 6901 et seq.

Robinson–Patman Act 15 U.S.C. § 13

Sarbanes-Oxley Act 15 U.S.C. § 7201 et seq.

Securities Act of 1933 15 U.S.C. § 77a et seq.

Sentencing Reform Act of 1984 18 U.S.C. § 3551 et seq.

Sherman Act 15 U.S.C. § 1 et seq.

Social Security Act 42 U.S.C. § 301 et seq.

Stark Law 42 U.S.C. § 1395nn

Toxic Substances Control Act 15 U.S.C. § 2601 et seq.

Evaluating the effectiveness of newborn and child screening and followup programs

42 U.S. Code § 300b-9. Evaluating the effectiveness of newborn and child screening and followup programs

Navigation

Table of Contents

952.933.4977

952.988.0141